Health Technology

DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals

DuPont Collaborates with STMicroelectronics

DuPont announced that DuPont™ Liveo™ Healthcare Solutions is collaborating with STMicroelectronics a global leader in semiconductor technology serving customers across the spectrum of electronics applications, to develop a new smart wearable device concept for remote biosignal-monitoring.

"Dedicated Liveo™ research teams collaborate with suppliers and manufacturers worldwide to create solutions across a vast array of medical applications – including smart devices that can share data between patients and doctors," said DuPont™ Liveo™ Global Business Leader Eugenio Toccalino. "The wearable device concept that resulted from the collaboration between DuPont and ST is the DuPont™ Liveo™ Smart Biosensing Patch prototype, which employs multifunctional microsensors and control electronics from ST embedded in a flexible patch design from DuPont."

By collaborating with others across the healthcare ecosystem – from technology developers and material suppliers to device fabricators and OEMs – DuPont is developing more patient-centric solutions that contribute to better patient outcomes.

Simone Ferri, STMicroelectronics AMS Group Vice-President and MEMS sub-group General Manager. 

ST designed the electronics and sensors for the smart skin patch prototype using our accelerometer and vertical analog front end next-generation sensors with in-sensor AI, a microcontroller with Bluetooth module, ultra-low-power-management units, firmware, and algorithm support to create a flexible board design capable to analyze electrical and mechanical heart activity in full synchronization to extract multiple vital signs. The performance of ST's electronic sensors is enhanced by the conformability and conductivity of the DuPont™ Liveo™ materials used to create the patch.

[Source: PR Newswire]

Through this collaboration, DuPont brings a broad range of medical patch technologies, including DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for sensing and transferring electrical biosignals, and Liveo™ Soft Skin Adhesives.

ST's sensor and embedded development technology and semiconductor manufacturing expertise, combined with the key benefits of silicone technology with electrically conductive properties allow Liveo™ Soft Skin Conductive Tape technology to be used as a skin electrode for biosignal-monitoring applications where good skin conformability, no drying over time, and repositionability with gentle adhesion and atraumatic removal is vital. It can be used in single electrodes for short-term monitoring, as well as in medical wearable patches for long-term monitoring lasting seven or more days.

DuPont also designed the layout for the Liveo™ Smart Biosensing Patch and supplied rapid prototyping capabilities.

The result of this collaboration is not just a single prototype, but a robust ST-empowered Liveo™ Smart Biosensing Patch technology toolbox for remote ECG and SCG monitoring.

The DuPont and ST integrated patch technology is designed to improve people's lives, making it easier to use than typical rigid box designs. It's smaller, lighter, and more comfortable and can be worn longer. Plus, the sensors are multifunctional, intelligent, and adaptable, and the data provided is extremely stable.

DuPont will demonstrate the capabilities of the Liveo™ Smart Biosensing Patch prototype at the MEDICA Trade Fair in Dusseldorf, Germany, November 13-16. The Liveo™ team will be in Hall 12/D33 in the Wearable Technologies Pavilion.

As part of the MEDICA Connected Healthcare Forum, DuPont™ Liveo™ Healthcare Solutions Global Strategic Marketing Manager Jennifer Gemo and ST's Head of EMEA Healthcare and Well-Being Vertical Strategic Business Development Oriana Di Marco will present "Towards intelligent e-skin patches for cardiac monitoring" featuring the DuPont/ST collaborative patch concept and technology toolbox. The presentation will take place on Nov. 14 from 12:15 to 12:35 p.m. CEST in Hall 12/E37.

DuPont offers a broad portfolio of high-performance, medical-grade elastomers, adhesives, resins and thermoplastics designed to meet the rigorous requirements of wearable medical devices. The company also provides support in the areas of materials research, application development, technology, safety and regulatory compliance.

Whether for drug delivery or smart monitoring devices, DuPont™ Liveo™ Healthcare Solutions helps enable positive patient outcomes through increasingly advanced medical technology.

Spotlight

Spotlight

Related News

Medical Devices

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

Medtronic | January 05, 2024

Medtronic plc a global leader in healthcare technology, announced it has received CE Mark for its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniature, leadless pacemakers. Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers.2 With approximately 40% more battery life compared to previous generations,1 Medtronic projects the battery life of Micra AV2 and Micra VR2 is nearly 16 and 17 years, respectively.3 This means more than 80% of patients who receive a Micra may only require one device for life.3 This CE Mark milestone follows U.S. Food and Drug Administration approval for the Micra AV2 and VR2 devices in 2023. In addition to size and longevity benefits, Micra devices are also the only leadless pacemakers with remote monitoring capabilities, which allow a doctor or clinic to check on a patient's heart device without the need for a patient to travel to their clinic for an in-person appointment. Other patient benefits of remote monitoring may include a reduction in hospitalizations and increase in sense of security.4,5 "For more than eight years, our Micra leadless pacemakers have provided meaningful benefits to people in Europe who require a pacemaker. Now, these patients have access to the latest leadless pacing technology that, for most of them, may be the only device they will ever need," said Robert C. Kowal, M.D., Ph.D., general manager, Cardiac Pacing Therapies within the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic. "The first generation of leadless Micra pacemakers demonstrated a significant reduction in major complications, and this next generation of Micra brings several additional benefits including greater longevity, and specifically for the Micra AV2, new algorithms to optimize AV synchrony at faster heart rates while requiring less in-office programming," said Prof. Dr. Christophe Garweg, Cardiologist at University Hospitals of Leuven, Belgium. "These advantages likely will expand the use of the leadless pacemaker to more patients." Globally, more than 200,000 patients have received Micra pacemakers.6 Comparable in size to a large vitamin, Micra pacemakers are less than one-tenth the size of traditional pacemakers. Unlike traditional pacemakers, Micra pacemakers do not require leads or a surgical "pocket" under the skin, so potential sources of complications related to leads and pockets are eliminated, and there is no visible sign of the device. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

Read More

Health Technology

Rudolf Riester GmbH Announces Global Market Launch of Telemedicine Solution, Showcases ri-sonic® E-Stethoscope + eMurmur® AI Integration

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providing accurate and efficient diagnostic devices for front-line healthcare. We have brought this passion and expertise to the creation of our telemedicine solution," said Dr. Georgiana Gasquères, Global Business Unit Director, Telemedicine at Riester. "Now we empower healthcare providers worldwide with the tools they need to deliver accurate diagnosis and exceptional care to every patient, everywhere, and to do it more sustainably." Riester is demonstrating its Telemedicine Case and Cart offerings at the Arab Health show in Dubai, 29 January – 1 February 2024, at booth SA.E30. Traveling nurses with South African healthcare innovator EQiGate are already evaluating dozens of patients every week with the Riester Telemedicine Case. "EQiGate selected the Riester Telemedicine solution for its high quality, comprehensiveness, and versatile, Windows-based compatibility with our portfolio of operating applications," stated Braam Kruger, CEO at EQiGate. "The Riester solution integrates seamlessly with our Hospital at Home concept, enabling us to bring the hospital to the patient, a healthcare paradigm shift that yields significant cost and time savings for both the healthcare system and the patient." At Arab Health, Riester is showcasing the integration of their industry-leading ri-sonic® E-stethoscope with the eMurmur® AI platform. Digital auscultation with ri-sonic and eMurmur AI enables the early detection and analysis of heart murmurs, informing better, more timely decisions about treatment pathways. To demonstrate their commitment to raising heart health awareness and improving quality of life through accurate and efficient diagnosis, Riester is offering complimentary advisory heart checks to all exhibition attendees at their booth at Arab Health, conducted by a professional cardiologist. "Our participation at Arab Health reaches beyond showcasing our technological advancements; it is about educating and engaging with the public – including Arab Health attendees – and healthcare professionals," said Irina Zhdanova, CEO of Riester. "By providing free advisory heart checks, we emphasise the significance of regular cardiac health assessments and demonstrate how innovative technology can be a pivotal tool in advancing diagnostic cardiac care to improve health outcomes. This is a perfect way to honor Riester’s 75-year heritage and act on our vision and mission." About Rudolf Riester GmbH Since its founding in Germany in 1948, Rudolf Riester GmbH has been a pioneering force in improving quality of life through accurate and efficient diagnosis on the front-line of healthcare. By developing and manufacturing high-quality, market-leading medical diagnostic products, Riester has earned a global reputation for quality, reliability, and innovation in the healthcare sector, with a presence in over 150 countries. Specializing in diagnostic devices, Riester's product portfolio includes telemedicine solutions as well as stethoscopes, blood pressure monitors, otoscopes, ophthalmoscopes, and other medical equipment. Riester is part of the Halma plc group of companies.

Read More

Healthcare Analytics

Keystone Healthcare Partners Establishes Partnership with Trinity Medical to Expand Emergency Medicine Footprint into Louisiana

Keystone Healthcare Partners | February 05, 2024

Keystone Healthcare Partners a leading provider of emergency medicine, hospital medicine, critical care medicine, and telehealth staffing and management services, as well as revenue cycle management, recently announced that it has formed a partnership with Trinity Medical in Ferriday, Louisiana. Keystone's delivery of emergency medicine services at Trinity Medical will commence on February 1, 2024. This contract represents an exciting expansion of Keystone's regional influence into Louisiana; the company has managed contracts in Mississippi for decades. Glenn Adams, Keystone's CEO & Co-founder, notes, "We are excited to kick off another partnership with a client where we see opportunity for real impact. We've hit the ground running to shore up areas of frustration for the client and bring value-add and innovative solutions, such as Keystone Connect AI technology to the emergency medicine program." While the healthcare landscape has been challenging for rural and critical access hospitals, the two entities share a patient-centered ethos that will be paramount to the partnership. The two entities share a community- and patient-focus that is embodied by Trinity's motto, "People you know, caring for people you love." "We are very excited to start our partnership with Keystone Healthcare," states Keisha Smith, CEO of Trinity. "My goal for Trinity Medical has always been to provide our patients with the best healthcare and customer service possible in the Miss-Lou area. We feel that Keystone shares the same goals that we have and will be a true asset to our hospital. Henry Ford stated, 'Coming together is a beginning, staying together is progress, and working together is success.' We are looking forward to a long lasting, successful partnership with Keystone Healthcare." Trinity Medical, a 23-bed licensed facility, continues to grow and upgrade their services and facilities in addition to recruiting physicians to meet the growing needs of their expanding community. About Keystone Healthcare Keystone Healthcare™ is a leading provider of Emergency Medicine, Hospital Medicine, Critical Care Medicine and Telehealth clinical management services and staffing solutions for hospitals. We efficiently deliver high-quality, patient-centered care through strong physician leadership and involved management that drive our innovative and integrated business model. About Trinity Medical Trinity Medical is operated by Concordia Parish Hospital Service District No. 1. Trinity Medical, formerly Riverland Medical Center, opened in 1964 as Concordia Parish Hospital and has continuously served the residents of the area for more than 55 years. In addition to emergency and acute care, Trinity Medical offers surgical services, diagnostic imaging, infusion center, cardio-respiratory care, gastroenterology, lab services, otolaryngology, urology, and an in-hospital rehabilitation service as well as an extensive range of out-patient services, both diagnostic and for treatment.

Read More